Media attention following our publication and opinion article in The BMJ concerning the added benefit and revenues of anticancer medicines (see publications):
29/02/2024 - PhD candidate Francine Brinkhuis on Medscape
01/03/2024 - Professor Wim Goettsch on the Dutch BNR (radio news)
12/03/2024 - Interview with dr. Lourens Bloem and PhD candidate Francine Brinkhuis for OncLive
20/02/2024 - Interview with PhD candidate Christine van Hattem about our report 'Advanced Therapy Medicinal Products (ATMPs) in the Netherlands: Field Map, Bottleneck Analysis, and Activity Map' (title translated from Dutch; report in Dutch) for the media network Euractiv.
05/12/2022 - Interview with dr. Lourens Bloem and dr. Friso Smit about the Regulatory Science workstream of Oncode Accelerator for the Regulatory Science magazine of the Dutch Medicines Evaluation Board.